5XN0
HIV-1 reverse transcriptase Q151M:DNA binary complex
5XN0 の概要
エントリーDOI | 10.2210/pdb5xn0/pdb |
関連するPDBエントリー | 4ZHR |
関連するBIRD辞書のPRD_ID | PRD_900003 |
分子名称 | Pol protein, 38-MER DNA aptamer, beta-D-fructofuranose-(2-1)-alpha-D-glucopyranose, ... (6 entities in total) |
機能のキーワード | hiv-1, hbv, reverse transcriptase, drug resistance, drug sensitivity, transferase-dna complex, transferase/dna |
由来する生物種 | Human immunodeficiency virus 1 詳細 |
タンパク質・核酸の鎖数 | 6 |
化学式量合計 | 256041.64 |
構造登録者 | |
主引用文献 | Yasutake, Y.,Hattori, S.I.,Hayashi, H.,Matsuda, K.,Tamura, N.,Kohgo, S.,Maeda, K.,Mitsuya, H. HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir. Sci Rep, 8:1624-1624, 2018 Cited by PubMed Abstract: Hepatitis B virus (HBV) reverse transcriptase (RT) is essential for viral replication and is an important drug target. Nonetheless, the notorious insolubility of HBV RT has hindered experimental structural studies and structure-based drug design. Here, we demonstrate that a Q151M substitution alone at the nucleotide-binding site (N-site) of human immunodeficiency virus type-1 (HIV-1) RT renders HIV-1 highly sensitive to entecavir (ETV), a potent nucleoside analogue RT inhibitor (NRTI) against HBV. The results suggest that Met151 forms a transient hydrophobic interaction with the cyclopentyl methylene of ETV, a characteristic hydrophobic moiety of ETV. We thus solved the crystal structures of HIV-1 RT:DNA complex with bound dGTP or ETV-triphosphate (ETV-TP). The structures revealed that ETV-TP is accommodated at the N-site slightly apart from the ribose ring of the 3'-end nucleotide, compared to the position of bound dGTP and previously reported NRTI/dNTP. In addition, the protruding methylene group of bound ETV-TP directly pushes the side-chain of Met184 backward. Met184 is a key residue that confers ETV resistance upon substitution with smaller Ile/Val. These results provide novel insights into NRTI binding to the N-site and further provide important clues for the development of novel anti-HBV/HIV-1 RT inhibitors to overcome critical drug resistance. PubMed: 29374261DOI: 10.1038/s41598-018-19602-9 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.596 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード